Neuro-ophthalmologic initial presentation of sarcoidosis;Manifestations neuro-ophtalmologiques révélatrices d'une neuro-sarcoïdose

Journal Francais d'Ophtalmologie

Volumn 29, Issue 3, 2006, Pages 241-249

  Lamirel, C ^a,b   Badelon, I ^b,c   Gout, O ^b   Berthet, K ^d   Heran F ^b   Laloum, L ^e   Cochereau, I ^a   Gaudric, A ^d   Bousser, M G ^d   Vignal Clermont, C ^b,d  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD   (France)

^c AVICENNE HOSPITAL   (France)

^d HÔPITAL LARIBOISIÈRE   (France)

^e Cabinet Medical   (France)

Author keywords

Cavernous sinus; Oculomotor palsies; Optic chiasm; Optic neuropathy; Papilledema; Sarcoidosis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADULT; ARTICLE; BIOPSY; CAVERNOUS SINUS; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIPLOPIA; DISEASE COURSE; ENZYME BLOOD LEVEL; FEMALE; HISTOLOGY; HUMAN; LUMBAR PUNCTURE; MALE; NEUROOPHTHALMOLOGY; OPHTHALMOPLEGIA; OPTIC CHIASM; OPTIC NERVE; OPTIC NERVE DISEASE; OPTIC NERVE LESION; PAPILLEDEMA; PROTEIN CEREBROSPINAL FLUID LEVEL; RADICULITIS; RELAPSE; RETROSPECTIVE STUDY; SARCOIDOSIS; THORAX RADIOGRAPHY; TIME SERIES ANALYSIS; VISUAL SYSTEM;

EID: 33645322147     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0181-5512(06)73779-2     Document Type: Article

References (26)

1. Yamamoto M, Sharma OP, Hosoda Y. Special report: the 1991 descriptive definition of sarcoidosis. Sarcoidosis, 1992;9:33-4.
2. Seamone CD, Nozik RA. Sarcoidosis and the eye. Ophthalmol Clin North Am, 1992;5:567-76.
3. Obenauf CD, Shaw HE, Sydnor CF, Klintworth GK. Sarcoidosis and its ophthalmic manifestations Am J Ophthalmol, 1978;86:648-55.
4. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999.Am J Respir Crit Care Med, 1999; 160:736-55.
5. Rybicki BA, Major M, Popovich JJr, Maliarik MJ, Ianuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organisation. Am J Epidemiol, 1997;145:234-41.
6. Martinetti M, Tinelli C, Kolek V, Cuccia M, Salvaneschi L, Pasturenzi L et al. "The sarcoidosis map": a joint survey of clinical and immunogenetic finding in two European countries. Am J Respir Crit Care Med, 1995;152:557-64.
7. Berlin M, Fogdell-Hahn A, Olerup O, Eklund A, Grunewald J. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Resp Crit Care Med, 1997; 156:1601-5.
8. Buck AA. Epidemiologic investigation of sarcoidosis: IV. Discussion and summary. Am J Hyg, 1961;74:189-202.
9. Henke CE, Henke G, Elveback LR, Beard CM, Ballard DJ, Kurland LT. The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival. Am J Epidemiol, 1986;123:840-5.
10. Gordis L. Sarcoidosis: epidemiology of chronic lung diseases in children. The John Hopkins University Press, Baltimore. 1973. pp. 53-78.
11. De Vust P, Dumortier P, Schandene L, Estenne M, Verhest A, Yernault JC. Sarcoid like lung granulomatosis induced by aluminum dust. AM Rev Respir Dis, 1987;135:493-7.
12. Skelton HGD, Smith KJ, Johnson FB, Cooper CR, Tyler WF, Lupton GP. Zirconium granuloma resulting from an aluminium zirconium complex: a previously unrecognized agent in the development of hypersensitivity granulomas. J Am Acad Dermatol, 1993;28:874-6.
13. Hunninghake GW, Crystal RG. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med, 1981;305:429-34.
14. Semenzato GA, Pezzutto A, Chilosi M, Pizzolo G. Redistribution of T lymphocytes in the lymph nodes of patients with sarcoidosis. N Engl J Med, 1982;306:48-9.
15. Chapelon C, Ziza JM, Piette JC, Levy Y, Raguin G, Bousser MG et al. Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine, 1990;69: 261-76.
16. Oksanen VE. Neurosarcoidosis. In: DG James, editor. Sarcoidosis and Other Granulomatous Disorders. Marcel Dekker, New York. 1994; pp. 285-309.
17. Heuser K, Kerty E. Neuro-ophthalmological findings in sarcoidosis. Acta Ophthalmol Scand, 2004;82:723-9.
18. Frohman LP, Grigorian R, Bielory L. Neuro-ophthalmic manifestation of sarcoidosis: clinical spectrum, evaluation, and management. J Neuro-Ophthalmol, 2001;21:132-7.
19. Frohman LP, Guirgis M, Turbin RE, Bielory L. Sarcoidosis of the anterior visual pathway: 24 new cases. J Neuro-Ophthalmol, 2003;23:190-7.
20. Costabel U. Sensitivity and specificity of BAL findings in sarcoidosis. Sarcoidosis, 1992;9(Suppl. 1):211-4.
21. Winterbauer RH, Lammert J, Selland M, Wu R, Corley D, Springmeyer SC. Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis. Chest, 1993;104:352-61.
22. Gilman MJ, Wang KP. Transbronchial lung biopsy in sarcoidosis: an approach to determine the optimal number of biopsies. Am Rev Respir Dis, 1980;122: 721-4.
23. Stjernberg N, Bjornstad-Pettersen H, Truedsson H. Flexible fiberoptic bronchoscopy in sarcoidosis. Acta Med Scand, 1980;208: 397-9.
24. Armstrong JR, Radke JR, Kvale PA, Eichenhorm MS, Popovich J. Endoscopic findings in sarcoidosis: characteristics and correlations with radiographic staging and bronchial mucosal biopsy yield. Ann Otol Rhinol Laryngol, 1981;90:339-43.
25. Gossot D, Toledo L, Fritsch S, Celerier M. Mediastinoscopy vs thoracoscopy for mediastinal biopsy: results of a prospective nonrandomized study. Chest, 1996;110:1328-31.
26. Raghu G. Interstitial lung disease: a diagnostic approach. Are CT scan and lung biopsy indicated in every patient? Am J Respir Crit Care Med, 1995;151:909-14.